Plate Nº 22 · recorded October 7, 2026
Biology & EvolutionReported finding
What Happens Within 48 Hours of Losing p53, Cancer's Guardian Gene
UT Southwestern researchers switched off p53, the gene mutated in over half of cancers, and saw cancer-like metabolism, jumping genes and sperm-and-egg programs activate within 48 hours.
By James Calloway3 min read658 words
In brief
- p53 is mutated in more than half of all cancers.
- Cells switched to Warburg metabolism within 48 hours of p53 loss.
- The study is the first to examine immediate p53 loss at single-cell level in real time.
- Tamoxifen-triggered engineered mouse cells allowed timed gene shutdown.
- Published in Genes & Development (2026), DOI: 10.1101/gad.353794.126.
Within 48 hours of switching off the p53 gene, healthy cells switch their energy supply to a mode typical of tumors, according to a new study from UT Southwestern Medical Center published in Genes & Development (2026). The finding suggests that a hallmark of cancer metabolism appears almost immediately after the gene is disabled — not later, as many researchers had assumed.
p53, often called the "guardian of the genome," is mutated in more than half of all cancers. Yet scientists have known surprisingly little about what the gene actually does day-to-day to keep cells healthy, because until now they had no reliable way to observe the moment it stops working.
"The p53 gene is widely recognized as the most commonly mutated cancer gene," said John Abrams, Ph.D., professor of cell biology at UT Southwestern and corresponding author of the study. "Our work is the first to examine the immediate consequences of p53 loss at the single-cell level in real time."
Why was it so hard to study p53 loss?
The gene protects cells by activating tumor-suppressing genes and turning off tumor-driving genes when DNA is damaged by things like toxic chemicals or ionizing radiation. But Abrams and others suspected p53 also has a "steady-state" job in unstressed cells.
Testing that idea was difficult. In the usual research models — tumor cells from patients, genetically engineered mice, or cell lines with the gene deleted — a long lag separates the loss of p53 from the cancerous changes that follow. Everything observed after that delay is muddied by secondary effects.
To see the immediate aftermath, the researchers genetically engineered mouse cells so that p53 would switch off only after exposure to a drug called tamoxifen. That gave them a clean, timed snapshot of what happens first.
What changes in the first two days?
Three shifts stood out:
- A metabolic switch. Cells without working p53 abandoned oxidative phosphorylation — the process healthy cells use to extract energy from nutrients with oxygen — in favor of Warburg metabolism, in which cells burn large amounts of glucose through fermentation that produces lactic acid. This is the same energy strategy used by cancer cells, and it appeared within 48 hours.
- Waking "jumping genes." Retrotransposons, stretches of DNA that can move around the genome and are normally dormant in healthy cells, became reactivated immediately after p53 loss, with widespread effects across the genome.
- Reproductive programs switched on. The cells quickly activated genetic programs normally seen only in sperm and eggs, including genes needed for meiosis, the type of cell division that produces cells with a single copy of each chromosome.
The speed of the metabolic switch is notable. Some researchers had hypothesized that Warburg metabolism is a long-term consequence of tumor development. Abrams explained that the new results suggest it is instead a relatively immediate response once p53 is disabled.
Could this lead to cancer prevention?
How these early changes eventually turn healthy cells malignant is still unknown. Abrams said his team will investigate that question in future studies.
But the findings point toward possible prevention strategies for people at high risk, such as those with familial cancer syndromes. If reactivated retrotransposons play a significant role in driving cancer after p53 loss, doctors might eventually prescribe reverse transcriptase inhibitors — drugs already used to treat HIV/AIDS that are also known to inhibit retrotransposons — to lower cancer risk.
That application remains speculative for now. The study was conducted in mouse cells engineered in the lab, and the chain of events leading from gene loss to malignancy has not yet been traced. Still, by capturing the first hours after p53 disappears, the work gives researchers a clearer starting point for understanding how the most commonly mutated gene in cancer fails — and perhaps how to intervene before tumors form.
The study appears as Yang Fan et al., "Initial perturbations triggered by p53 loss in stem cells," Genes & Development (2026), DOI: 10.1101/gad.353794.126.
via Phys.org Biology (Source)
More from James Calloway
Nearby plates
- Cells That Cheat Death May Explain Healing and Cancer Relapse
- Enzyme's Hidden Second Job May Drive Breast Cancer Drug Resistance
- Personalized Guidance Helps Families Act on Cancer Risk Genes
- Lung Cancers Evade KRAS Drugs by Switching Cell Type
- New Immune Cell Atlas Links Genetic Variants to Disease Mechanisms